Clinical Trial Update: 131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol

View source ↗

Summary

This document reports a compassionate-use protocol for 131I-labeled metaiodobenzylguanidine (MIBG) to treat refractory neuroblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• 131I-labeled MIBG (metaiodobenzylguanidine (MIBG))

Snippet

Sponsor: Kieuhoa Vo | Conditions: Neuroblastoma | Status: AVAILABLE